NEWS

WIRES

OTHER

Pathway Genomics Licenses Harvard Health Content for Personalized Genetic Test Reports

"When customers review their Genetic Health Reports they want to easily access detailed information-from a trusted source—about health conditions reported with their genetic results," said Michael Nova, M.D., Chief Medical Officer at Pathway Genomics. "By drawing on the expertise of Harvard Medical School and Harvard Health Publications we can help our customers quickly obtain this information and provide answers to common questions."

The Pathway Genomics Genetic Health Report currently reports on more than 70 health conditions, including an individual's propensity for disease, carrier status, and drug response. For each complex disease reported, customers can access additional information about the condition. For example, information about diabetes informs customers that there are three types of diabetes mellitus: type 1 diabetes, type 2 diabetes, and gestational diabetes. Symptoms of diabetes usually come on suddenly and strong, diagnosis of this health condition is completed by testing the blood for sugar levels, and prognosis for people with type 1 diabetes is that they generally adjust quickly to the time and attention that is needed to monitor blood sugar, treat the disease, and maintain a normal lifestyle.

"Genetic testing tells us with great accuracy if an individual has a particular genetic marker, but it does not predict with absolute certainty whether that person will or will not develop that disease," said Linda Wasserman, M.D., Ph.D., Director of Clinical Genetics and head of Pathway's genetic counseling team. "This is where the role of genetic counseling comes into play, and it is a critical factor in helping customers understand their genetic results. By providing additional content from experts at Harvard Medical School and Harvard Health Publications on our web site, we can quickly refer our customers to a source of information that is current and accurate."

About Pathway Genomics

Located in San Diego, California, Pathway Genomics is a privately held, venture-backed company that offers both genetic health and ancestry reports. Using customized and innovative DNA genetic testing technologies, Pathway Genomics generates personalized reports about an individual's carrier status, pharmacogenomics (drug response), propensity for complex disease and ancestral history. Pathway Genomics has both its federal CLIA and California state licenses for its wholly owned and operated onsite laboratory. In this laboratory, Pathway Genomics performs all genetic testing in a controlled and secure environment. The Company offers personal genetic tests directly to the consumer as well as through partnerships with select health management organizations. More information about Pathway Genomics can be found at www.PATHWAY.com.

Pathway Genomics
Media
Maurissa Bornstein
Maurissa.Bornstein@pathway.com
858-997-0826
or
Partnerships & Alliances
Jim Woodman
Jim.Woodman@pathway.com
858-771-0533